Join Lyndsay Malchuk on Market Frontlines as she interviews Hugh Rogers, CEO of BioNxt Solutions, a biotech company shaking up the industry by reformulating existing drugs using their patented sublingual oral dissolvable platform. Discover how BioNxt Solutions accelerates drug development, manages investor expectations, builds a robust patent portfolio, and positions itself for strategic growth or acquisition. Learn what truly sets BioNxt apart from traditional biotech firms and why this could be the next big move in healthcare innovation.
Share This Post